Clinical Trial Update: A Study of Individualized Stereotactic Body Radiation Therapy (SBRT) for Intrahepatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating individualized stereotactic body radiotherapy for intrahepatic cancers has completed and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Liver Cancer, Hepatocellular Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-03-09